BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
23 results:

  • 1. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.
    Wu M; Xie J; Xing Y; Zhang L; Chen H; Tang B; Zhou M; Lv S; Huang D; Jian S; Zhou C; Liu M; Guo W; Chen Y; Yi Z
    Int J Biol Sci; 2024; 20(2):486-501. PubMed ID: 38169532
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian cancer.
    Pi Y; Sun F; Zhang Z; Liu X; Lou G
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
    [No Abstract]    [Full Text] [Related]  

  • 3. Nuclear receptor co-repressor ncor2 and its relation to GPER with prognostic impact in ovarian cancer.
    Reichenbach J; Fraungruber P; Mayr D; Buschmann C; Kraus FBT; Topalov NE; Chelariu-Raicu A; Kolben T; Burges A; Mahner S; Kessler M; Jeschke U; Czogalla B; Trillsch F
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8719-8728. PubMed ID: 37131060
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic cancer.
    Du Y; Gu Z; Li Z; Yuan Z; Zhao Y; Zheng X; Bo X; Chen H; Wang C
    Adv Sci (Weinh); 2022 Jun; 9(18):e2200818. PubMed ID: 35570408
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): A retrospective cohort study.
    Landry JP; Pieterman CRC; Clemente-Gutierrez U; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
    Surgery; 2022 May; 171(5):1240-1246. PubMed ID: 34952716
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.
    Taylor JA; Burnell M; Ryan A; Karpinskyj C; Kalsi JK; Taylor H; Apostolidou S; Sharma A; Manchanda R; Woolas R; Campbell S; Parmar M; Singh N; Jacobs IJ; Menon U; Gentry-Maharaj A
    BJOG; 2022 Jan; 129(1):110-118. PubMed ID: 34555263
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model.
    Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM
    World J Surg; 2021 Jul; 45(7):2134-2141. PubMed ID: 33768309
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circular RNA circ-ncor2 accelerates papillary thyroid cancer progression by sponging miR-516a-5p to upregulate metastasis-associated protein 2 expression.
    Luan S; Fu P; Wang X; Gao Y; Shi K; Guo Y
    J Int Med Res; 2020 Sep; 48(9):300060520934659. PubMed ID: 32940102
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.
    Fekete JT; Ősz Á; Pete I; Nagy GR; Vereczkey I; Győrffy B
    Gynecol Oncol; 2020 Mar; 156(3):654-661. PubMed ID: 31973910
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma.
    Xu H; Duan N; Wang Y; Sun N; Ge S; Li H; Jing X; Liang K; Zhang X; Liu L; Xue C; Zhang C
    Pathology; 2020 Feb; 52(2):206-212. PubMed ID: 31883669
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.
    Matsumoto I; Kamei K; Omae K; Suzuki S; Matsuoka H; Mizuno N; Ozaka M; Ueno H; Kobayashi S; Uesugi K; Kobayashi M; Todaka A; Fukutomi A
    Pancreatology; 2019 Mar; 19(2):296-301. PubMed ID: 30638853
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy.
    Okano K; Murakami Y; Nakagawa N; Uemura K; Sudo T; Hashimoto Y; Kondo N; Takahashi S; Sueda T
    Surgery; 2016 Mar; 159(3):885-92. PubMed ID: 26603844
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms.
    Koh YX; Zheng HL; Chok AY; Tan CS; Wyone W; Lim TK; Tan DM; Goh BK
    Surgery; 2015 Mar; 157(3):496-509. PubMed ID: 25656693
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Prevalence of thyroid nodules and influencing factors among employees of a company in Qingdao].
    Zhu HF; Yang Y; Li JY; Li XM; Ma AG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Mar; 46(3):228-32. PubMed ID: 22800593
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis.
    Bremmer F; Thelen P; Pottek T; Behnes CL; Radzun HJ; Schweyer S
    Anticancer Res; 2012 Jan; 32(1):341-9. PubMed ID: 22213325
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
    Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
    Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical and molecular features of a TSH-secreting pituitary microadenoma.
    Usui T; Izawa S; Sano T; Tagami T; Nagata D; Shimatsu A; Takahashi JA; Naruse M
    Pituitary; 2005; 8(2):127-34. PubMed ID: 16379036
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
    Hussein-Fikret S; Fuller PJ
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):149-60. PubMed ID: 15607539
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.
    Kelley KM; Rowan BG; Ratnam M
    Cancer Res; 2003 Jun; 63(11):2820-8. PubMed ID: 12782587
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.